Clinical Trials in San Antonio

Showing 8781-8800 of 11,125 trials

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

NCT00802867

Objectives: * To present the rates of adverse reactions after a dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine. * To present immunogenicity before and after a single dose of DAPTACEL® vaccine administered to children 4 to 6 years of age who have previously received four doses of PENTACEL™ vaccine.

DiphtheriaTetanusPertussis+2 more

Sanofi Pasteur, a Sanofi Company989 participantsStarted Feb 2004

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Oakland, California, United States +16 more locations

COMPLETEDPhase 2< 1 mile

Dose Comparison Study of Menactra® in US Children

NCT00700635

To explore the potential benefit of the administration of Menactra vaccine as a two-dose regimen to children. Primary Objective: To assess, by age group, the immune response to Menactra vaccine after each vaccine injection.

MeningitisMeningococcal InfectionNeisseria Meningitidis

Sanofi Pasteur, a Sanofi Company333 participantsStarted Jun 2008

Jonesboro, Arkansas, United States • Little Rock, Arkansas, United States • Boca Raton, Florida, United States +12 more locations

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Dose Comparison Study of Menactra® in US Children

Find Trials by Condition in San Antonio

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis

A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

Niacin Plus Statin to Prevent Vascular Events

Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Major Depressive Disorder With Mixed Features - Extension

The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions

Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE-2)